| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
EpothiloneIxabepilone| 1 | 2007 | Potential clinical applications of epothilones: a review of phase II studies. | 
| + | - | nl | Ann Oncol 18 Suppl 5(-):v28-34 (2007) |
| 2 | 2007 | Epothilones in prostate cancer: review of clinical experience. |
| + | - | nl | Ann Oncol 18 Suppl 5(-):v22-7 (2007) |
| 3 | 2007 | Epothilones in breast cancer: review of clinical experience. |
| + | - | nl | Ann Oncol 18 Suppl 5(-):v16-21 (2007) |
| 4 | 2008 | The epothilones: translating from the laboratory to the clinic. |
| + | - | nl | Clin Cancer Res 14(6):1618-24 (2008) |
| 5 | 2008 | Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors. |
| + | - | nl | Oncologist 13(12):1207-23 (2008) |
| 6 | 2007 | Targeting the microtubules in breast cancer beyond taxanes: the epothilones. |
| + | - | nl | Oncologist 12(3):271-80 (2007) |
| 7 | 2007 | Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues. |
| + | - | nl | Ann Oncol 18 Suppl 5(-):v9-15 (2007) |
